Načítá se...
Use of pulmonary arterial hypertension–specific therapy in overweight or obese patients with obstructive sleep apnea and pulmonary hypertension
Abstract. Pulmonary hypertension (PH) in overweight or obese patients with obstructive sleep apnea (OSA) may be multifactorial. The effect of pulmonary artery hypertension (PAH)–specific drugs on PH and exercise capacity in such patients is unknown. We performed a retrospective review of overweight...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
University of Chicago Press
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4070789/ https://ncbi.nlm.nih.gov/pubmed/25006443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/675987 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|